Prohost Letter #408
AT A GLANCE -
Continued from the Previous Prohost Letter #408
In the Past issue #407, we picked the following firms:
NEUROCRINE BIOSCIENCES (NBIX)
Treating Tardive Dyskinesia
Improving On Cancer Immunotherapy
CELYAD SA (CYAD)
Bringing Solutions To Immunotherapy Problems
Please Read the articles written about these firms in the Issue #407
In This Issue We Add
NEW LINK GENETICS...
This content is for paid subscribers.
Prohost Letters April 25, 2017